A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With a Non-Myeloid Malignancy
Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy of darbepoetin alfa administered using a
front-loading approach with subjects receiving standard weekly dosing in the treatment of
anemia in subjects with a non-myeloid malignancy and receiving multicycle chemotherapy.